Acucela (4589.JP)

US-based biotechnology company that develops treatments for eye diseases.

Health Care - Pharmaceuticals

IPO Performance
Latest Trade $1080.00 0.00 (0.0%)
First Day Return 12705.2%
Return from IPO 6032.9%
 
Acucela IPO News more
  • .
IPO Data
IPO File Date 12/17/2013
Offer Price $17.61
Price Range $16.14 - $17.61
Offer Shares (mm) 9.2
Deal Size ($mm) 162
 
IPO Data
IPO Date 02/03/2014
Offer Price $17.61
Price Range $16.14 - $17.61
Offer Shares (mm) 9.2
Deal Size ($mm) $162
 
Underwriters
more
Business Overview
US-based biotechnology company that develops treatments for eye diseases.
US-based biotechnology company that develops treatments for eye diseases.
more
Company Data
Headquarters ,
Founded
Employees n/a
Website
 

Performance vs. IPO Index (IPOUSA)